We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Milestone Is Reached For New Leukemia Drug

News   Nov 20, 2019 | Original story from Cold Spring Harbor Laboratory

 
A Milestone Is Reached For New Leukemia Drug

Bioluminescence imaging of mice whose cancer cells were tagged with a firefly-derived enzyme shows how the drug YKL-05-099 blocks the SIK3 pathway to slow the progression of leukemia. Credit: Vakoc lab/CSHL, 2019.

 
 
 

RELATED ARTICLES

Test Predicts Chance of Living More Than a Year on Targeted Breast Cancer Treatment

News

A new test could pick out women with advanced breast cancer who are likely to benefit from a novel targeted therapy for more than a year.

READ MORE

An Engineered Probiotic Could Be a Novel Treatment Avenue for Inflammatory Bowel Disease

News

A research team has developed a living material approach that uses a strain of genetically engineered E.coli Nissle gut bacteria as a locally acting probiotic.

READ MORE

Ancient Worm Reveals a Way To Destroy Toxic Cells in Huntington's Disease

News

A highly conserved mechanism in worms and humans has been identified, that controls the removal of toxic protein aggregates – hallmarks of neurodegenerative diseases. Insights from their study may provide a novel therapeutic approach for Huntington's and Parkinson's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE